可解释的人工智能模型揭示了癌症类型分类的信息突变特征
Jonas Wagner1, Jan Oldenburg1, Neetika Nath1
1Institute of Bioinformatics, University Medicine Greifswald, 17475 Greifswald, Germany.
Cancers
|June 13, 2025
概括
突变特征,当用人工智能分析时,与单独的驱动基因突变相比,显著改善了癌症类型的预测. 这种方法通过揭示修复机制故障来提高诊断准确性.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 在瘤学中使用人工智能
背景情况:
- 传统上,癌症类型的预测依赖于驱动基因和突变.
- 奥米克技术为改善癌症诊断提供了新的遗传数据.
- 突变签名提供了对DNA修复故障的洞察力,有助于癌症诊断.
研究的目的:
- 为了比较用于癌症类型预测的机器学习方法.
- 利用人工智能和omics数据来提高癌症诊断的准确性.
- 为了研究突变特征与驱动基因突变对癌症分类的有用性.
主要方法:
- 对比无监督和监督的机器学习模型,包括深度和人工神经网络.
- 在癌症类型预测中利用层次相关性传播来提取特征.
- 优化神经网络架构使用十倍交叉验证和网格搜索与驱动基因突变,突变签名和来自PCAWG数据集的拓突变信息.
主要成果:
- 使用整个基因组或基因间/内基因区域,与外基因组数据相比,突变信息的相关性增加了10%以上.
- 突变特征对癌症类型的歧视更相关,而不是大多数癌症类型的拓突变信息.
- 该方法成功地区分了17个主要部位和24种癌症类型.
结论:
- 与驱动基因突变相比,信息化的突变特征提供了优越的癌症类型预测,增加了诊断价值.
- 突变特征可以根据不同的相关突变从相同的原始部位区分癌症类型.
- 对突变特征的分析使得能够分配特定的受损DNA修复机制,并有助于癌症类型的分类.
相关概念视频
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K